The Archive
-
US targets 10 drugs for pricing negotiations in crackdown on costs -
Blue blood of horseshoe crabs puts pharma groups under scrutiny
-
Eli Lilly achieves hard-won success with Alzheimer’s and obesity drugs
-
Novo Nordisk’s obesity drug cuts risk of strokes and heart attacks
-
Lawsuit alleges blockbuster weight-loss drugs cause ‘stomach paralysis’
-
How a Swedish start-up reignited the search for an Alzheimer’s drug But then a new treatment showed promise
-
Experimental gene therapy tests US system of fast-track drug approval
-
Drugmaker warns US data rules threaten access to Alzheimer’s treatment
-
Big Pharma dealmaking recovers with $85bn M&A splurge
-
Merck accuses US of ‘extortion’ in lawsuit against drug price controls
